Galectin Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GALT and other ETFs, options, and stocks.About GALT
Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments.
CEOJoel Lewis
CEOJoel Lewis
Employees15
Employees15
HeadquartersNorcross, Georgia
HeadquartersNorcross, Georgia
Founded2000
Founded2000
Employees15
Employees15
GALT Key Statistics
Market cap203.75M
Market cap203.75M
Price-Earnings ratio-5.41
Price-Earnings ratio-5.41
Dividend yield—
Dividend yield—
Average volume486.46K
Average volume486.46K
High today$3.24
High today$3.24
Low today$2.94
Low today$2.94
Open price$3.20
Open price$3.20
Volume671.80K
Volume671.80K
52 Week high$7.13
52 Week high$7.13
52 Week low$1.07
52 Week low$1.07
Stock Snapshot
As of today, Galectin Therapeutics(GALT) shares are valued at $3.15. The company's market cap stands at 203.75M, with a P/E ratio of -5.41.
On 2026-01-09, Galectin Therapeutics(GALT) stock traded between a low of $2.94 and a high of $3.24. Shares are currently priced at $3.15, which is +7.1% above the low and -2.8% below the high.
Galectin Therapeutics(GALT) shares are trading with a volume of 671.8K, against a daily average of 486.46K.
During the past year, Galectin Therapeutics(GALT) stock moved between $1.07 at its lowest and $7.13 at its peak.
During the past year, Galectin Therapeutics(GALT) stock moved between $1.07 at its lowest and $7.13 at its peak.
People also own
Based on the portfolios of people who own GALT. This list is generated using Robinhood data, and it’s not a recommendation.